Clinical Trial Update: Artemether/Lumefantrine and Vivax Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating artemether/lumefantrine for vivax malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vivax Malaria

Drugs mentioned

• Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: University of Khartoum | Conditions: Vivax Malaria | Phase 3 | Status: COMPLETED